KRAS as a modulator of the inflammatory tumor microenvironment: therapeutic implications

KRAS mutations are one of the most frequent oncogenic mutations of all human cancers, being more prevalent in pancreatic, colorectal, and lung cancers. Intensive efforts have been encouraged in order to understand the effect of KRAS mutations, not only on tumor cells but also on the dynamic network...

ver descrição completa

Detalhes bibliográficos
Autor principal: Pereira, Flávia (author)
Outros Autores: Ferreira, Anabela (author), Reis, Celso Albuquerque (author), Sousa, Maria João (author), Oliveira, Maria José (author), Preto, Ana (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
Texto completo:https://hdl.handle.net/1822/78321
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/78321